Cargando...
Cost effectiveness of pharmacogenetic testing for UGT1A1 before irinotecan administration for metastatic colorectal cancer
PURPOSE: To examine the cost effectiveness of using a pharmacogenetic test for UGT1A1*28 variant homozygosity before administering irinotecan in metastatic colorectal cancer patients. Patients and Methods: Decision-analytic model from Medicare payer perspective followed hypothetical patients treated...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2009
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2853177/ https://ncbi.nlm.nih.gov/pubmed/19517472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24428 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|